Skip to main content
Top
Published in: BMC Nephrology 1/2015

Open Access 01-12-2015 | Research article

Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease

Authors: Jinnie J. Rhee, Victoria Y. Ding, David H. Rehkopf, Cristina M. Arce, Wolfgang C. Winkelmayer

Published in: BMC Nephrology | Issue 1/2015

Login to get access

Abstract

Background

Maintaining tight glycemic control is important for prevention of diabetes-related outcomes in end-stage renal disease patients with diabetes, especially in light of their poor prognosis. This study aimed to determine factors associated with poor glycemic control among U.S. patients with diabetes mellitus initiating hemodialysis for end-stage renal disease.

Methods

Using data from the U.S. Renal Data System, electronic health records of a large national dialysis provider, and U.S. Census data, we performed a cross-sectional multivariable Poisson regression analysis to characterize risk factors associated with poor glycemic control, defined as glycated hemoglobin (HbA1c) >7 vs. ≤7 %, in adult patients with diabetes who initiated hemodialysis at an outpatient facility between 2006 and 2011.

Results

Of 16,297 patients with diabetes, 21.2 % had HbA1c >7 %. In multivariable analysis, younger patients, patients of Native American race, and those of Hispanic ethnicity had higher prevalence of poor glycemic control. Independent correlates of poor glycemic control further included higher platelet count, white blood cell count, and ferritin; higher body mass index, systolic blood pressure, total cholesterol and triglyceride concentrations; lower HDL and albumin concentrations; lower normalized protein catabolic rate; and higher estimated glomerular filtration rate at initiation of dialysis (all P < 0.05). No independent associations were found with area-level socioeconomic indicators. Occurrence of diabetes in patients <40 years of age, a proxy for type 1 diabetes, was associated with poor HbA1c control compared with that in patients ≥40 years of age, which was classified as type 2 diabetes. These findings were robust to the different outcome definitions of HbA1c >7.5 % and >8 %.

Conclusion

In this cohort of incident end-stage renal disease patients with diabetes, poor glycemic control was independently associated with younger age, Native American race, Hispanic ethnicity, higher body mass index, and clinical risk factors including atherogenic lipoprotein profile, hypertension, inflammation, and markers indicative of malnutrition and a more serious systemic disease.
Literature
2.
go back to reference Abbott KC, Bakris GL. Treatment of the diabetic patient: Focus on cardiovascular and renal risk reduction. Prog Brain Res. 2002;139:289–98.CrossRefPubMed Abbott KC, Bakris GL. Treatment of the diabetic patient: Focus on cardiovascular and renal risk reduction. Prog Brain Res. 2002;139:289–98.CrossRefPubMed
3.
4.
go back to reference Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007;30:1049–55.CrossRefPubMed Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007;30:1049–55.CrossRefPubMed
5.
go back to reference American Diabetes Association. Standards of medical care in diabetes (position statement). Diabetes Care. 2005;28(Suppl):4–36.CrossRef American Diabetes Association. Standards of medical care in diabetes (position statement). Diabetes Care. 2005;28(Suppl):4–36.CrossRef
6.
go back to reference Dunn PJ, Cole RA, Soeldner JS, Gleason RE. Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance. Ann Intern Med. 1979;91:390–6.CrossRefPubMed Dunn PJ, Cole RA, Soeldner JS, Gleason RE. Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance. Ann Intern Med. 1979;91:390–6.CrossRefPubMed
7.
go back to reference Calisti L, Tognetti S. Measure of glycosylated hemoglobin. Acta Biomed. 2005;76 Suppl 3:59–62.PubMed Calisti L, Tognetti S. Measure of glycosylated hemoglobin. Acta Biomed. 2005;76 Suppl 3:59–62.PubMed
8.
go back to reference American Diabetes Association. Standards of medical care in diabetes (position statement). Diabetes Care. 2004;27(Suppl):15–35. American Diabetes Association. Standards of medical care in diabetes (position statement). Diabetes Care. 2004;27(Suppl):15–35.
9.
go back to reference Akmal M. Hemodialysis in diabetic patients. Am J Kidney Dis. 2001;38 Suppl 1:195–9.CrossRef Akmal M. Hemodialysis in diabetic patients. Am J Kidney Dis. 2001;38 Suppl 1:195–9.CrossRef
10.
go back to reference National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60:850–86.CrossRef National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60:850–86.CrossRef
11.
go back to reference Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications. 2010;24:84–9.CrossRefPubMed Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications. 2010;24:84–9.CrossRefPubMed
12.
go back to reference National Kidney Foundation. 2013 USRDS annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis. 2014;63(Supp):e1–e478. National Kidney Foundation. 2013 USRDS annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis. 2014;63(Supp):e1–e478.
13.
go back to reference Krieger N, Waterman P, Chen JT, Soobader MJ, Subramanian SV, Carson R. Zip code caveat: Bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas--the Public Health Disparities Geocoding Project. Am J Public Health. 2002;92:1100–2.PubMedCentralCrossRefPubMed Krieger N, Waterman P, Chen JT, Soobader MJ, Subramanian SV, Carson R. Zip code caveat: Bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas--the Public Health Disparities Geocoding Project. Am J Public Health. 2002;92:1100–2.PubMedCentralCrossRefPubMed
14.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.PubMedCentralCrossRefPubMed Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.PubMedCentralCrossRefPubMed
15.
go back to reference Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman A, Magee JC, Cibrik D, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation. 2001;71:82–90.CrossRefPubMed Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman A, Magee JC, Cibrik D, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation. 2001;71:82–90.CrossRefPubMed
16.
go back to reference Nichols GA, Hillier TA, Javor K, Brown JB. Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care. 2000;23:273–7.CrossRefPubMed Nichols GA, Hillier TA, Javor K, Brown JB. Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care. 2000;23:273–7.CrossRefPubMed
17.
go back to reference Rothenbacher D, Rüter G, Saam S, Brenner H. Younger patients with type 2 diabetes need better glycaemic control: Results of a community-based study describing factors associated with a high HbA1c value. Br J Gen Pract. 2003;53:389–91.PubMedCentralPubMed Rothenbacher D, Rüter G, Saam S, Brenner H. Younger patients with type 2 diabetes need better glycaemic control: Results of a community-based study describing factors associated with a high HbA1c value. Br J Gen Pract. 2003;53:389–91.PubMedCentralPubMed
18.
go back to reference Glasgow RE, Hampson SE, Strycker LA, Ruggiero L. Personal-model beliefs and social-environmental barriers related to diabetes self-management. Diabetes Care. 1997;20:556–61.CrossRefPubMed Glasgow RE, Hampson SE, Strycker LA, Ruggiero L. Personal-model beliefs and social-environmental barriers related to diabetes self-management. Diabetes Care. 1997;20:556–61.CrossRefPubMed
19.
go back to reference Hemmelgarn BR, James MT, Manns BJ, O’Hare AM, Muntner P, Ravani P, et al. Rates of treated and untreated kidney failure in older vs younger adults. JAMA. 2012;307:2507–15.CrossRefPubMed Hemmelgarn BR, James MT, Manns BJ, O’Hare AM, Muntner P, Ravani P, et al. Rates of treated and untreated kidney failure in older vs younger adults. JAMA. 2012;307:2507–15.CrossRefPubMed
20.
go back to reference Tamura MK, Winkelmayer WC. Treated and untreated kidney failure in older adults: What’s the right balance? JAMA. 2012;307:2545–6. Tamura MK, Winkelmayer WC. Treated and untreated kidney failure in older adults: What’s the right balance? JAMA. 2012;307:2545–6.
22.
go back to reference Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519–27.CrossRefPubMed Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519–27.CrossRefPubMed
23.
go back to reference Chaturvedi N, Jarrett J, Shipley MJ, Fuller JH. Socioeconomic gradient in morbidity and mortality in people with diabetes: Cohort study findings from the Whitehall Study and the WHO multinational study of vascular disease in diabetes. BMJ. 1998;316:100–5.PubMedCentralCrossRefPubMed Chaturvedi N, Jarrett J, Shipley MJ, Fuller JH. Socioeconomic gradient in morbidity and mortality in people with diabetes: Cohort study findings from the Whitehall Study and the WHO multinational study of vascular disease in diabetes. BMJ. 1998;316:100–5.PubMedCentralCrossRefPubMed
24.
go back to reference Connolly V, Kesson C. Socioeconomic status and clustering of cardiovascular disease risk factors in diabetic patients. Diabetes Care. 1996;19:419–22.CrossRefPubMed Connolly V, Kesson C. Socioeconomic status and clustering of cardiovascular disease risk factors in diabetic patients. Diabetes Care. 1996;19:419–22.CrossRefPubMed
25.
go back to reference Chan W, Tong P, Chow C, So W, Ng M, Ma R, et al. Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients. Diabetes Metab Res Rev. 2005;21:183–8.CrossRefPubMed Chan W, Tong P, Chow C, So W, Ng M, Ma R, et al. Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients. Diabetes Metab Res Rev. 2005;21:183–8.CrossRefPubMed
26.
go back to reference Faulkner MS, Chao W-H, Kamath SK, Quinn L, Fritschi C, Maggiore JA, et al. Total homocysteine, diet, and lipid profiles in type 1 and type 2 diabetic and nondiabetic adolescents. J Cardiovasc Nurs. 2006;21:47–55.PubMedCentralCrossRefPubMed Faulkner MS, Chao W-H, Kamath SK, Quinn L, Fritschi C, Maggiore JA, et al. Total homocysteine, diet, and lipid profiles in type 1 and type 2 diabetic and nondiabetic adolescents. J Cardiovasc Nurs. 2006;21:47–55.PubMedCentralCrossRefPubMed
27.
go back to reference Ko G, Chan J, Woo J, Lau E, Yeung V, Chow CC, et al. Glycated haemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance. Diabet Med. 1998;15:573–8.CrossRefPubMed Ko G, Chan J, Woo J, Lau E, Yeung V, Chow CC, et al. Glycated haemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance. Diabet Med. 1998;15:573–8.CrossRefPubMed
28.
go back to reference Ladeia AM, Adan L, Couto‐Silva AC, Hiltner Â, Guimarães AC. Lipid profile correlates with glycemic control in young patients with type 1 diabetes mellitus. Prev Cardiol. 2006;9:82–8.CrossRefPubMed Ladeia AM, Adan L, Couto‐Silva AC, Hiltner Â, Guimarães AC. Lipid profile correlates with glycemic control in young patients with type 1 diabetes mellitus. Prev Cardiol. 2006;9:82–8.CrossRefPubMed
29.
go back to reference Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996;49:1379–85.CrossRefPubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996;49:1379–85.CrossRefPubMed
30.
go back to reference Festa A, D’Agostino R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes the insulin resistance atherosclerosis study. Diabetes. 2002;51:1131–37.CrossRefPubMed Festa A, D’Agostino R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes the insulin resistance atherosclerosis study. Diabetes. 2002;51:1131–37.CrossRefPubMed
31.
go back to reference Aramwit P, Satirapoj B. Glycemic control in diabetic patients on long-term maintenance dialysis. INTECH Open Access Publisher. 2013.doi:10.5772/52479. Aramwit P, Satirapoj B. Glycemic control in diabetic patients on long-term maintenance dialysis. INTECH Open Access Publisher. 2013.doi:10.​5772/​52479.
32.
go back to reference Rao RH. The role of undernutrition in the pathogenesis of diabetes mellitus. Diabetes Care. 1984;7:595–601.CrossRefPubMed Rao RH. The role of undernutrition in the pathogenesis of diabetes mellitus. Diabetes Care. 1984;7:595–601.CrossRefPubMed
33.
go back to reference Grootendorst DC, Michels WM, Richardson JD, Jager KJ, Boeschoten EW, Dekker FW, et al. The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transplant. 2011;26:1932–37.CrossRefPubMed Grootendorst DC, Michels WM, Richardson JD, Jager KJ, Boeschoten EW, Dekker FW, et al. The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transplant. 2011;26:1932–37.CrossRefPubMed
34.
go back to reference Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int. 1993;44:115–9.CrossRefPubMed Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int. 1993;44:115–9.CrossRefPubMed
35.
go back to reference Owen Jr WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329:1001–6.CrossRefPubMed Owen Jr WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329:1001–6.CrossRefPubMed
36.
go back to reference Prasad N, Gupta A, Sinha A, Sharma RK, Saxena A, Kaul A, et al. Confounding effect of comorbidities and malnutrition on survival of peritoneal dialysis patients. J Ren Nutr. 2010;20:384–91.CrossRefPubMed Prasad N, Gupta A, Sinha A, Sharma RK, Saxena A, Kaul A, et al. Confounding effect of comorbidities and malnutrition on survival of peritoneal dialysis patients. J Ren Nutr. 2010;20:384–91.CrossRefPubMed
37.
go back to reference Ansari A, Thomas S, Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis. 2003;41:523–31.CrossRefPubMed Ansari A, Thomas S, Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis. 2003;41:523–31.CrossRefPubMed
38.
go back to reference Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J, et al. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant. 2014;29:2167–77.CrossRefPubMed Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J, et al. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant. 2014;29:2167–77.CrossRefPubMed
39.
go back to reference Abbott KC, Bernet VJ, Agodoa LY, Yuan CM. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States. BMC Endocr Disord. 2003;3:1.PubMedCentralCrossRefPubMed Abbott KC, Bernet VJ, Agodoa LY, Yuan CM. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States. BMC Endocr Disord. 2003;3:1.PubMedCentralCrossRefPubMed
Metadata
Title
Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease
Authors
Jinnie J. Rhee
Victoria Y. Ding
David H. Rehkopf
Cristina M. Arce
Wolfgang C. Winkelmayer
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2015
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-015-0204-4

Other articles of this Issue 1/2015

BMC Nephrology 1/2015 Go to the issue